+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)


Ambulatory Blood Pressure Monitoring Market: By Procedure; By End-use; By Product and Geography - Forecast 2016-2021

  • ID: 3820863
  • Report
  • March 2016
  • Region: Global
  • 144 pages
  • IndustryARC
1 of 3
Ambulatory blood pressure monitoring is defined as the frequent measurement of blood pressure after fixed interval of time which usually varies from 15 to 30 minutes and the monitoring of patient is performed for 24 hours of time. The procedure is majorly used to monitor patients suffering from hypertension due to increased monitoring, masked hypertension, episodic hypertension, hypertension due to anti-hypersensitive medicine and to differentiate white-collar and true hypertension.

This report identifies the Ambulatory Blood Pressure Monitoring market size in terms of value for the year 2014-2016, and forecast of the same for year 2021. It highlights potential growth opportunities in the coming years, while also reviewing the market drivers, restraints, growth indicators, challenges, market dynamics, competitive landscape, and other key aspects with respect to Ambulatory Blood Pressure Monitoring market.

This report has been divided based on product type which includes Ambulatory BP Monitors, Sphygmomanometers, BP Transducers, BP Cuffs and Others.

This report also includes Ambulatory Blood Pressure Monitoring market by Procedure type which includes Invasive and Non-Invasive procedure.

The report is also segmented on the basis of the end-use into Hospital, Home Care Settings, Ambulatory Surgical Centers & Clinics, Diagnostic Laboratories and Others.

This is report has been further segmented into major regions, which includes detailed analysis of each region such as Americas, Europe, Asia-Pacific (APAC) and Rest of the World (RoW).
Country level markets for each of the regions are also analyzed and determined. The major countries considered under the Americas region are Argentina, Brazil and the North American region. The major countries considered under the Asia-Pacific region are China, Japan, India, South Korea and others. The major countries considered under the European region are United Kingdom, France, Germany and others.

Ambulatory blood pressure monitoring

Globally demand for Ambulatory Blood Pressure Monitoring is expected to witness growth in the upcoming future due to rapidly increasing prevalence of Chronic & Acute Diseases and the rapid increase in aging population. The major factor restraining the substantial growth of Ambulatory Blood Pressure Monitoring is the high cost of technological development and availability of low-cost devices. North America and Europe has the highest markets share by value in global Ambulatory Blood Pressure Monitoring market and Asia Pacific region is projected to have a significant growth during the forecast period.

This market research report includes in depth analysis of Ambulatory Blood Pressure Monitoring in each application and in the regional segment separately to provide in depth view of key insights and market scenario. Forecasts are also provided for all the market segments for the period 2016-2021.

This report also includes detailed profiling of following major players in the global Ambulatory Blood Pressure Monitoring market:

Philips Healthcare
GE Healthcare
Medtronic PLC
Drägerwerk Ag & Co. KGAA
Welch Allyn
Please Note: The report is to be delivered in 1-2 working days after an order is placed.
Note: Product cover images may vary from those shown
2 of 3
1. Ambulatory Blood Pressure Monitoring – Market Overview

2. Executive Summary

3. Ambulatory Blood Pressure Monitoring – Market Landscape
3.1. Market Share Analysis
3.2. Comparative Analysis
3.2.1. Product Benchmarking
3.2.2. End User Profiling
3.2.3. Top 5 Financials Analysis

4. Ambulatory Blood Pressure Monitoring – Market Forces
4.1. Market Drivers
4.1.1. Rapidly increasing prevalence of Chronic and Acute Diseases
4.1.2. Rapid increase in Aging Population
4.2. Market Constraints
4.2.1. High Cost of Technological Development
4.2.2. Availability of Low-Cost Devices
4.3. Market Challenges
4.3.1. Regulatory Hurdles
4.4. Attractiveness of the Ambulatory Blood Pressure Monitoring Industry
4.4.1. Power of Suppliers
4.4.2. Power of Customers
4.4.3. Threat of New Entrants
4.4.4. Threat of Substitution
4.4.5. Degree of Competition

5. Ambulatory Blood Pressure Monitoring Market – Strategic Analysis
5.1. Value Chain Analysis
5.2. Pricing Analysis
5.3. Opportunities Analysis
5.4. Product/Market Life Cycle Analysis
5.5. Suppliers and Distributors

6. Ambulatory Blood Pressure Monitoring Market – By Procedure:
6.1. Invasive
6.2. Non-Invasive

7. Ambulatory Blood Pressure Monitoring Market- By End-Use:
7.1. Hospital
7.2. Home Care Settings
7.3. Ambulatory Surgical Centers and Clinics
7.4. Diagnostic Laboratories and
7.5. Others

8. Ambulatory Blood Pressure Monitoring Market- By Product:
8.1. Ambulatory BP Monitors
8.2. Sphygmomanometers
8.3. BP Transducers
8.4. BP Cuffs
8.5. Others

9. Ambulatory Blood Pressure Monitoring Market - By Geography:
9.1. Introduction
9.2. Global Study
9.3. Americas
9.3.1. North America
9.3.2. Brazil
9.3.3. Argentina
9.3.4. Others
9.4. Europe
9.4.1. U.K.
9.4.2. France
9.4.3. Germany
9.4.4. Others
9.5. APAC
9.5.1. China
9.5.2. South Korea
9.5.3. Japan
9.5.4. India
9.5.5. Others
9.6. ROW

10. Market Entropy
10.1. New Product Launches
10.2. M&As, Collaborations, JVs and Partnerships

11. Company Profiles
11.1. Philips Healthcare
11.1.1. Introduction
11.1.2. Financials
11.1.3. Key Insights
11.1.4. Key Strategy
11.1.5. Product Portfolio
11.1.6. SWOT Analysis
11.2. GE Healthcare
11.2.1. Introduction
11.2.2. Financials
11.2.3. Key Insights
11.2.4. Key Strategy
11.2.5. Product Portfolio
11.2.6. SWOT Analysis
11.3. Medtronic PLC
11.3.1. Introduction
11.3.2. Financials
11.3.3. Key Insights
11.3.4. Key Strategy
11.3.5. Product Portfolio
11.3.6. SWOT Analysis
11.4. Drägerwerk Ag & Co. KGAA
11.4.1. Introduction
11.4.2. Financials
11.4.3. Key Insights
11.4.4. Key Strategy
11.4.5. Product Portfolio
11.4.6. SWOT Analysis
11.5. Welch Allyn
11.5.1. Introduction
11.5.2. Financials
11.5.3. Key Insights
11.5.4. Key Strategy
11.5.5. Product Portfolio
11.5.6. SWOT Analysis
11.6. Becton, Dickinson and Company
11.6.1. Introduction
11.6.2. Financials
11.6.3. Key Insights
11.6.4. Key Strategy
11.6.5. Product Portfolio
11.6.6. SWOT Analysis
11.7. Nihon Kohden Corporation
11.7.1. Introduction
11.7.2. Financials
11.7.3. Key Insights
11.7.4. Key Strategy
11.7.5. Product Portfolio
11.7.6. SWOT Analysis
11.8. Nonin Medical Inc.
11.8.1. Introduction
11.8.2. Financials
11.8.3. Key Insights
11.8.4. Key Strategy
11.8.5. Product Portfolio
11.8.6. SWOT Analysis
11.9. Smiths Medical
11.9.1. Introduction
11.9.2. Financials
11.9.3. Key Insights
11.9.4. Key Strategy
11.9.5. Product Portfolio
11.9.6. SWOT Analysis
11.10. A&D Medical
11.10.1. Introduction
11.10.2. Financials
11.10.3. Key Insights
11.10.4. Key Strategy
11.10.5. Product Portfolio
11.10.6. SWOT Analysis
*More than 40 Companies are profiled in this Research Report, Complete List available on Request*
"*Financials would be provided on a best efforts basis for private companies"

12. Appendix
12.1. Abbreviations
12.2. Sources
12.3. Research Methodology
12.4. Bibliography
12.5. Compilation of Expert Insights
12.6. Disclaimer
Note: Product cover images may vary from those shown
3 of 3


4 of 3